Focal Points with Brom Rector

7: Compass Pathways Deep Dive - Patents, Peter Thiel and the Quest for a Psychedelic Monopoly


Listen Later

🍄 Compass Pathways is the largest psychedelic stock by market cap, and was famously backed by Paypal and Palantir Founder Peter Thiel.  In this episode I investigate Compass Pathways and answer questions like:

  • What does Compass Pathway's FDA therapy designation mean for their future?    
  • What does Peter Thiel want to do with psychedelics?     
  • What's the deal with Compass Pathways patent strategy?  Can you really patent soft furniture, dark rooms and cool music?    
  • What's Compass Pathway's beef with Dr. Bronners Soap?    
  • Who wins in the battle between Compass Pathways and Non-Profits    
  • What are the risks to Compass Pathway's business?     
  • And of course the ultimate question for investors:  is Compass Pathways a Buy?
  •    

    📺Watch on YouTube:

    https://youtu.be/ha2GMoZ7s60


    📹 Clips Channel: 

    https://www.youtube.com/channel/UCDzauugr4QA5dfcwaE1rweQ


    🎇 Clips and other stuff on Instagram: 

    https://instagram.com/bromtalks


    🐦 brom on twitter:

    https://twitter.com/therealbrom


    Disclaimer: This recording is not financial advice.  You should not make any investment or trading decision based on the contents of this recording.  Do not consider anything in this video to be professional advice.  Brom holds long positions in Compass Pathways as well as other psychedelic stocks.

    ...more
    View all episodesView all episodes
    Download on the App Store

    Focal Points with Brom RectorBy Brom Rector and Focalpoint Partners

    • 5
    • 5
    • 5
    • 5
    • 5

    5

    6 ratings


    More shows like Focal Points with Brom Rector

    View all
    Pivot by New York Magazine

    Pivot

    8,534 Listeners

    All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

    All-In with Chamath, Jason, Sacks & Friedberg

    8,385 Listeners